Abstract
AbstractBackground: The prostate undergoes gradual growth throughout men’s lives, resulting in development of lower urinary tract symptoms due to benign prostatic hyperplasia (LUTS/BPH). The aim of this review was to determine whether Thermobalancing could be used for conservative treatment of LUTS/BPH. Methods and Results: Men older than 55 with LUTS derived to BPH used Thermobalancing therapy enabled by therapeutic device as mono-therapy. The main group consisted of 124 patients with the prostate volume (PV) up to 60 ml, however, there were also men with the prostate volume (PV) over 60 ml that were studied separately. Before and after six months Thermobalancing the International Prostate Symptom Score (IPSS) lessened (p < 0.001), quality of life (QoL) index improved, ultrasound PV reduced (p < 0.001) and uroflowmetry maximum flow rate (Qmax) increased (p < 0.001). The dynamics of the same measurements in the watchful waiting or active surveillance control group have shown negative outcomes. Discussion ...
Highlights
The prostate undergoes gradual growth throughout men’s lives, resulting in development of lower urinary tract symptoms due to benign prostatic hyperplasia (LUTS/BPH)
Patients with mild symptoms or moderate-to-severe symptoms of benign prostatic hyperplasia (BPH) who are not bothered by their symptoms and are not experiencing complications of BPH should be managed with a strategy of watchful waiting (American Urological Association (AUA), 2015)
Men randomised to three self-management sessions in addition to standard care had better symptom improvement and quality of life (QoL) than men treated with standard care only for up to a year (Gravas, Bach, & Bachmann, 2015)
Summary
The prostate undergoes gradual growth throughout men’s lives, resulting in development of lower urinary tract symptoms due to benign prostatic hyperplasia (LUTS/BPH). Patients with mild symptoms or moderate-to-severe symptoms of benign prostatic hyperplasia (BPH) who are not bothered by their symptoms and are not experiencing complications of BPH should be managed with a strategy of watchful waiting (American Urological Association (AUA), 2015). The eight studies enrolled 5,403 patients, of which 1,426 (26.4%) had metabolic syndrome (MetS) defined according to current classification, have shown that patients had significantly higher total prostate volume when compared with those without MetS. These studies verify the exacerbating role of MetS-induced metabolic derangements in the development of BPE (Gacci, Corona, & Vignozzi, 2015)
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
